Natco Pharma Limited is a vertically integrated ... The Company launched Chlorantraniliprole (CTPR) pesticide formulation and its combinationproducts in liquid and granule forms.

Natco Pharma on Tuesday shared a legal update on the legal proceedings on the Risdiplam compound (used for treating spinal ...

Also read: Front-end manufacturing in U.S. way forward to counter tariff impact on pharma: Natco Pharma CEO Aurobindo Pharma, Dr. Reddy’s Laboratories, Sun Pharma, Lupin, Cipla, Natco Pharma ...

Pharma index surged over 4 per cent in early trade on Thursday after US President Donald Trump’s administration exempted pharmaceutical products from reciprocal tariffs. Market and industry ...

Gland Pharma and IPCA Labs see gains close to 4% each. Even Lupin and Natco Pharma are rallying smartly. In a major relief, Indian pharmaceutical companies breathed a sigh of relief after US ...

2. NATCO PHARMA COLOMBIA SAS in Columbia which was approved by the Board of Directors at their meeting held on 29th May, 2023. 3. NATCO PHARMA UK LIMITED in United Kingdom, which was approved by ...

On Thursday's session Nifty Pharma surged nearly 4% with Gland Pharma, Lupin, Aurobindo Pharma, Natco Pharma, Sun Pharmaceutical Industries leading the gains. Rajesh Bhosale, Equity Technical and ...

Dr Reddy's Laboratories, Mankind Pharma, Natco Pharma and Ajanta Pharma were trading in the green with minor gains. US President Trump has called April 2 a 'Liberation Day' for the US economy ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

Top generics makers such as Cipla, Dr Reddy’s, Lupin, Natco Pharma, Mankind Pharma, and Biocon are all gearing up to launch cheaper generic copies of Ozempic. Meanwhile, India’s largest pharma ...

Aurobindo Pharma rose 1.51 per cent to end at ₹1,175.35 and Divi’s Laboratories were up 1.73 per cent to ₹5,764. The Department of Commerce is carefully examining the implications of the US ...